[Estrogen-progesterone "add-back" for long-term GNRH analogue therapy]

Levy T, T Levy, Ben-Rafael Z, Z Ben-Rafael
Harefuah · 1995 · vol. 128(12) , pp. 789–92 · PMID:7557691
Review public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-19 ⓘ

The paper discusses the use of estrogen-progesterone add-back therapy to support long-term treatment with GnRH analogues.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Estrogen Replacement Therapy Estrogen Replacement Therapy Gonadotropin-Releasing Hormone Endometriosis Endometriosis Endometriosis Female Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Humans Leiomyoma Leiomyoma Leiomyoma Uterine Neoplasms Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:58:54.395363+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine